免責事項: 本サイトは、FDA、ClinicalTrials.gov、PubMed、SEC EDGAR などの公式公開データを一般参考用に集約するものであり、医学的助言、診断、治療推奨、投資助言を構成しません。

PubMed

Use and regulation of patient-specific three-dimensional printing in medicine: a survey of physician end-users.

PMID: 41770469 ·

R, u, t, h, , S, h, a, y, l, o, r, ;, , Y, o, t, a, m, , L, i, o, r, ;, , J, i, l, l, i, a, n, , S, h, a, p, i, r, o, ;, , T, h, o, m, a, s, , F, e, r, r, e, t, t, o, ;, , F, r, a, n, k, , J, , R, y, b, i, c, k, i, ;, , J, a, s, a, m, i, n, e, , C, o, l, e, s, -, B, l, a, c, k

学術誌3D printing in medicine
年
PMID41770469

抄録

Technological advancements have made 3D printing more accessible and affordable for both individuals and institutions. Despite significant efforts by the International Medical Device Regulators Forum to standardize 3D printing regulations for medical use, challenges remain. We conducted a survey to gather insights from physician end-users on their opinions regarding the regulation of 3D printing in medicine. Additionally, since FDA guidance is often adopted internationally, this survey aimed to

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。

↑